托法替布治疗扁平苔藓性毛发角化病：一项回顾性研究。 - Suppr

Suppr

超能文献

Tofacitinib in the treatment of lichen planopilaris: A retrospective review.

作者信息

Plante John, Eason Chelsea, Snyder Alan, Elston Dirk

机构信息

Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, South Carolina.

出版信息

J Am Acad Dermatol. 2020 Nov;83(5):1487-1489. doi: 10.1016/j.jaad.2020.05.104. Epub 2020 May 29.

DOI:10.1016/j.jaad.2020.05.104

PMID:32473973

Abstract

摘要

相似文献

Tofacitinib in the treatment of lichen planopilaris: A retrospective review.

J Am Acad Dermatol. 2020 Nov;83(5):1487-1489. doi: 10.1016/j.jaad.2020.05.104. Epub 2020 May 29.

Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia.

J Am Acad Dermatol. 2024 Jun;90(6):1260-1262. doi: 10.1016/j.jaad.2024.01.060. Epub 2024 Feb 2.

Successful treatment of resistant lichen planopilaris with topical tofacitinib monotherapy.

Ann Dermatol Venereol. 2024 Sep;151(3):103303. doi: 10.1016/j.annder.2024.103303. Epub 2024 Aug 17.

Treatment of severe lichen planus with the JAK inhibitor tofacitinib.

J Allergy Clin Immunol. 2020 Jun;145(6):1708-1710.e2. doi: 10.1016/j.jaci.2020.01.031. Epub 2020 Feb 1.

Tofacitinib for the treatment of lichen planopilaris: A case series.

Dermatol Ther. 2018 Nov;31(6):e12656. doi: 10.1111/dth.12656. Epub 2018 Sep 27.

Esophageal lichen planus successfully treated with the JAK1/3 inhibitor tofacitinib.

J Dtsch Dermatol Ges. 2022 Jun;20(6):858-860. doi: 10.1111/ddg.14762. Epub 2022 Apr 28.

Treatment of lichen planopilaris with Janus kinase inhibitors.

Australas J Dermatol. 2024 Jun;65(4):381-383. doi: 10.1111/ajd.14240. Epub 2024 Feb 29.

Tofacitinib as Treatment for Nail Lichen Planus Associated With Alopecia Universalis.

JAMA Dermatol. 2021 Mar 1;157(3):352-353. doi: 10.1001/jamadermatol.2020.4555.

Remission of refractory esophageal lichen planus induced by tofacitinib.

Z Gastroenterol. 2024 Sep;62(9):1384-1388. doi: 10.1055/a-2300-0375. Epub 2024 Jun 25.

Tofacitinib in Hypertrophic Lichen Planus.

Acta Derm Venereol. 2020 Jul 28;100(14):adv00220. doi: 10.2340/00015555-3585.

引用本文的文献

The Use of Light-Based Therapies in the Treatment of Alopecia.

J Cosmet Dermatol. 2025 Sep;24(9):e70434. doi: 10.1111/jocd.70434.

Use of JAK Inhibitors in Lichen Planus: An Update.

Medicina (Kaunas). 2025 Jun 8;61(6):1056. doi: 10.3390/medicina61061056.

Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review.

Arch Dermatol Res. 2025 Jun 9;317(1):803. doi: 10.1007/s00403-025-04301-z.

Efficacy and Safety of Tofacitinib in Lichen Planopilaris: A Retrospective Series of 74 Patients.

Arch Iran Med. 2025 Jan 1;28(1):24-28. doi: 10.34172/aim.33237.

Lichen Planus: What is New in Diagnosis and Treatment?

Am J Clin Dermatol. 2024 Sep;25(5):735-764. doi: 10.1007/s40257-024-00878-9. Epub 2024 Jul 9.

Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies.

Dermatol Ther (Heidelb). 2024 Jun;14(6):1457-1477. doi: 10.1007/s13555-024-01186-0. Epub 2024 May 31.

The Frontal Fibrosing Alopecia Treatment Dilemma.

J Clin Med. 2024 Apr 7;13(7):2137. doi: 10.3390/jcm13072137.

Successful Treatment of Erosive Lichen Planus With Tofacitinib: A Case Series and Review of the Literature.

Clin Med Insights Case Rep. 2024 Mar 8;17:11795476241237350. doi: 10.1177/11795476241237350. eCollection 2024.

Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review.

PLoS One. 2024 Feb 9;19(2):e0293433. doi: 10.1371/journal.pone.0293433. eCollection 2024.

JAK Inhibitors in the Treatment of Lichen Planopilaris.

Skin Appendage Disord. 2024 Feb;10(1):10-17. doi: 10.1159/000534631. Epub 2023 Nov 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Tofacitinib in the treatment of lichen planopilaris: A retrospective review.

J Am Acad Dermatol. 2020 Nov;83(5):1487-1489. doi: 10.1016/j.jaad.2020.05.104. Epub 2020 May 29.

Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia.

J Am Acad Dermatol. 2024 Jun;90(6):1260-1262. doi: 10.1016/j.jaad.2024.01.060. Epub 2024 Feb 2.

Successful treatment of resistant lichen planopilaris with topical tofacitinib monotherapy.

Ann Dermatol Venereol. 2024 Sep;151(3):103303. doi: 10.1016/j.annder.2024.103303. Epub 2024 Aug 17.

Treatment of severe lichen planus with the JAK inhibitor tofacitinib.

J Allergy Clin Immunol. 2020 Jun;145(6):1708-1710.e2. doi: 10.1016/j.jaci.2020.01.031. Epub 2020 Feb 1.

Tofacitinib for the treatment of lichen planopilaris: A case series.

Dermatol Ther. 2018 Nov;31(6):e12656. doi: 10.1111/dth.12656. Epub 2018 Sep 27.

Esophageal lichen planus successfully treated with the JAK1/3 inhibitor tofacitinib.

J Dtsch Dermatol Ges. 2022 Jun;20(6):858-860. doi: 10.1111/ddg.14762. Epub 2022 Apr 28.

Treatment of lichen planopilaris with Janus kinase inhibitors.

Australas J Dermatol. 2024 Jun;65(4):381-383. doi: 10.1111/ajd.14240. Epub 2024 Feb 29.

Tofacitinib as Treatment for Nail Lichen Planus Associated With Alopecia Universalis.

JAMA Dermatol. 2021 Mar 1;157(3):352-353. doi: 10.1001/jamadermatol.2020.4555.

Remission of refractory esophageal lichen planus induced by tofacitinib.

Z Gastroenterol. 2024 Sep;62(9):1384-1388. doi: 10.1055/a-2300-0375. Epub 2024 Jun 25.

Tofacitinib in Hypertrophic Lichen Planus.

Acta Derm Venereol. 2020 Jul 28;100(14):adv00220. doi: 10.2340/00015555-3585.

引用本文的文献

The Use of Light-Based Therapies in the Treatment of Alopecia.

J Cosmet Dermatol. 2025 Sep;24(9):e70434. doi: 10.1111/jocd.70434.

Use of JAK Inhibitors in Lichen Planus: An Update.

Medicina (Kaunas). 2025 Jun 8;61(6):1056. doi: 10.3390/medicina61061056.

Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review.

Arch Dermatol Res. 2025 Jun 9;317(1):803. doi: 10.1007/s00403-025-04301-z.

Efficacy and Safety of Tofacitinib in Lichen Planopilaris: A Retrospective Series of 74 Patients.

Arch Iran Med. 2025 Jan 1;28(1):24-28. doi: 10.34172/aim.33237.

Lichen Planus: What is New in Diagnosis and Treatment?

Am J Clin Dermatol. 2024 Sep;25(5):735-764. doi: 10.1007/s40257-024-00878-9. Epub 2024 Jul 9.

Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies.

Dermatol Ther (Heidelb). 2024 Jun;14(6):1457-1477. doi: 10.1007/s13555-024-01186-0. Epub 2024 May 31.

The Frontal Fibrosing Alopecia Treatment Dilemma.

J Clin Med. 2024 Apr 7;13(7):2137. doi: 10.3390/jcm13072137.

Successful Treatment of Erosive Lichen Planus With Tofacitinib: A Case Series and Review of the Literature.

Clin Med Insights Case Rep. 2024 Mar 8;17:11795476241237350. doi: 10.1177/11795476241237350. eCollection 2024.

Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review.

PLoS One. 2024 Feb 9;19(2):e0293433. doi: 10.1371/journal.pone.0293433. eCollection 2024.

JAK Inhibitors in the Treatment of Lichen Planopilaris.

Skin Appendage Disord. 2024 Feb;10(1):10-17. doi: 10.1159/000534631. Epub 2023 Nov 9.